| AYTU Market Cap History Table | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Below is a table of the AYTU market cap history going back to 8/15/2017:
Also see: AYTU Shares Outstanding History and AYTU YTD Return |
AYTU Market Cap History — Aytu BioScience Capitalization Over Time
As of 9/15/2026 Aytu BioScience has a market cap of 21.62 million. Investors often follow the AYTU market cap history to compare the size of the company over time.
This page shows AYTU market capitalization trends over time, with 37 market cap datapoints presented, dating back to 8/15/2017.
| AYTU Market Cap History Chart | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
AYTU Historical Market Cap: +43.63% CAGR 
Mouse over chart for data details
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| AYTU Stock Price Chart |
| About AYTU BioPharma Inc |
| Aytu BioPharma, Inc. is a pharmaceutical company dedicated to commercializing novel therapeutics. Its Rx Segment focuses on prescription products primarily distributed through third-party wholesalers, featuring two main portfolios: ADHD and Pediatric. Key products include Adzenys XR-ODT and Cotempla XR-ODT, both extended-release orally disintegrating tablets for ADHD treatment. Additionally, the company offers Karbinal ER, an antihistamine for allergic conditions, and the fluoride-based vitamin lines Poly-Vi-Flor and Tri-Vi-Flor, designed for infants and children with fluoride deficiencies. We show 37 historical shares outstanding datapoints in our AYTU shares outstanding history coverage, used to compute AYTU market cap on those dates. Understanding the changing numbers of shares outstanding, the changing share price, and the resulting changing AYTU market cap history over the course of time is important for investors interested in comparing AYTU's market cap history versus its peers. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies, and then calculating their respective market caps. Comparing the share price of AYTU versus a peer is one thing; comparing AYTU market cap versus a peer is a completely different story. Furthermore, via fluctuation both in per-share price and in the number of shares outstanding (via issuance of new shares over time, the repurchase of existing shares), the market cap for a company like AYTU can fluctuate over the course of history. With this page we aim to empower investors researching AYTU by allowing them to research the AYTU market cap history. |
| AYTU Current Stock Quote |
Quotes delayed 20 minutes  Free AYTU Email Alerts:
Get Dividend Alerts 
Get SEC Filing Alerts
|
| Video: The Importance of Market Cap | |
|
Video: The Importance of Market Cap
| AYTU Share Performance |
| Market Cap Peers |
| Aytu BioScience (AYTU) is categorized under the Healthcare sector; to help you further research historical market cap numbers, below are some other companies in the same sector:
AZN Market Cap History AZRX Market Cap History AZYO Market Cap History BACK Market Cap History BASI Market Cap History BAX Market Cap History BBI Market Cap History BBIO Market Cap History BBLG Market Cap History BCAB Market Cap History More Healthcare companies » |
AYTU Market Cap History | www.MarketCapHistory.com | Copyright © 2017 - 2026, All Rights Reserved
Nothing in MarketCapHistory.com is intended to be investment advice, nor does it represent the opinion of, counsel
from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners.
None of the information contained herein constitutes a recommendation that any particular security, portfolio,
transaction, or investment strategy is suitable for any specific person. All viewers agree that under no
circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held
liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you
agree to the following Full Disclaimer & Terms of Use and
Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at
least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.
